Ionis Pharmaceuticals, Inc. (IONS)
USD 36.25
(-3.8%)
USD 36.25
(-3.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -307.51 Million | -274.37 Million | 30.79 Million | 35.89 Million | 345.72 Million | 602.88 Million |
| Net Income | -366.28 Million | -269.72 Million | -28.59 Million | -486.76 Million | 303.26 Million | 214.98 Million |
| Depreciation & Amortization | 22.49 Million | 22.1 Million | 19.56 Million | 17.16 Million | 15.99 Million | 12.52 Million |
| Deferred income taxes | -22.21 Million | - | 25.31 Million | 313.27 Million | -7.09 Million | -290.51 Million |
| Stock-based compensation | 105.8 Million | 100.26 Million | 120.67 Million | 230.11 Million | 146.57 Million | 131.31 Million |
| Change in working capital | -77.26 Million | 7.57 Million | -113.81 Million | -73.55 Million | -168.7 Million | 499.4 Million |
| Other non-cash items | 29.94 Million | -134.58 Million | 7.66 Million | 35.66 Million | 55.69 Million | 35.17 Million |
| Investing Cash Flow | -214.12 Million | -262.63 Million | 194.9 Million | 274.47 Million | -41.27 Million | -929.56 Million |
| Investments in PPE | -28.01 Million | -20.09 Million | -17.9 Million | -41.04 Million | -36.28 Million | -17.65 Million |
| Acquisitions | -4.2 Million | 254.08 Million | 5.94 Million | 5.92 Million | 5.37 Million | 4.04 Million |
| Investment purchases | -1.77 Billion | -1.48 Billion | -1.13 Billion | -1.57 Billion | -1.95 Billion | -1.79 Billion |
| Sales/Maturities of investments | 1.58 Billion | 989.15 Million | 1.34 Billion | 1.88 Billion | 1.95 Billion | 882.82 Million |
| Other Investing Activities | 4.22 Million | 254.08 Million | -5.94 Million | -5.92 Million | -5.37 Million | -4.04 Million |
| Financing Cash Flow | 644.08 Million | -55.29 Million | 245.93 Million | -596.6 Million | 100.02 Million | 475.86 Million |
| Debt repayment | -488.1 Million | -50.68 Million | -318.93 Million | - | -22.92 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -10.95 Million | -16.72 Million | -103.95 Million | -34.39 Million | - |
| Common Stock Issuance | 49.44 Million | 6.37 Million | 11.56 Million | 52.03 Million | 119.65 Million | 475.86 Million |
| Other Financing Activities | 1.08 Billion | -29 Thousand | 570.02 Million | -492.65 Million | 37.68 Million | 475.86 Million |
| Accounts receivables | -72.05 Million | 36.35 Million | 5.05 Million | -22 Million | -44.17 Million | 514 Thousand |
| Accounts payables | 8.11 Million | 1.09 Million | -6 Million | -2.75 Million | -16.34 Million | -655 Thousand |
| Inventory | -6.39 Million | 2.77 Million | -2.84 Million | -1.26 Million | -5.41 Million | 1.4 Million |
| Other working capital | -6.92 Million | -32.65 Million | -110.02 Million | -47.53 Million | -102.77 Million | 498.14 Million |
| Cash at beginning of period | 276.47 Million | 869.19 Million | 397.66 Million | 683.28 Million | 278.82 Million | 129.63 Million |
| Cash at end of period | 399.26 Million | 276.47 Million | 869.19 Million | 397.66 Million | 683.28 Million | 278.82 Million |
| Capital Expenditure | -28.01 Million | -20.09 Million | -17.9 Million | -41.04 Million | -36.28 Million | -17.65 Million |
| Effect of forex changes on cash | 352 Thousand | -418 Thousand | -111 Thousand | 617 Thousand | 93 Thousand | -18 Thousand |
| Net cash flow / Change in cash | 122.79 Million | -592.71 Million | 471.52 Million | -285.62 Million | 404.46 Million | 149.19 Million |
| Free Cash Flow | -335.52 Million | -294.46 Million | 12.89 Million | -5.15 Million | 309.43 Million | 585.23 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -66.26 Million | -142.8 Million | -366.28 Million | -9.26 Million | -147.41 Million | -85.29 Million |
| Depreciation & Amortization | 5.57 Million | 5.65 Million | 22.49 Million | 5.61 Million | 5.59 Million | 5.68 Million |
| Deferred income taxes | - | - | -22.21 Million | -5.35 Million | 6.43 Million | -19.23 Million |
| Stock-based compensation | 30.72 Million | 31.34 Million | 105.8 Million | 26.33 Million | 25.96 Million | 26.56 Million |
| Change in working capital | -94.02 Million | -45.52 Million | -77.26 Million | 12.98 Million | -3.67 Million | -31.56 Million |
| Other non-cash items | 69.76 Million | -32.89 Million | 29.94 Million | 2.54 Million | 4.07 Million | 6.47 Million |
| Investing Cash Flow | 62.45 Million | 76.1 Million | -214.12 Million | -26.71 Million | 68.71 Million | 69.51 Million |
| Investments in PPE | -20.26 Million | -5.73 Million | -28.01 Million | 819 Thousand | -3.24 Million | -13.07 Million |
| Acquisitions | - | - | -4.2 Million | 26.76 Million | 1.1 Million | 1.06 Million |
| Investment purchases | -284.86 Million | -519 Million | -1.77 Billion | -417.71 Million | -420.73 Million | -244.08 Million |
| Sales/Maturities of investments | 367.57 Million | 600.83 Million | 1.58 Billion | 390.95 Million | 492.69 Million | 326.67 Million |
| Other Investing Activities | 68.68 Million | 80.59 Million | 4.22 Million | -27.53 Million | -1.1 Million | -1.06 Million |
| Financing Cash Flow | 2.55 Million | 23.57 Million | 644.08 Million | 40.72 Million | -32.26 Million | 143.53 Million |
| Debt repayment | -39 Thousand | -39 Thousand | -488.1 Million | -38 Thousand | -67.83 Million | -420.19 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.59 Million | 23.6 Million | 49.44 Million | 40.76 Million | 3.73 Million | 2.39 Million |
| Other Financing Activities | 2.59 Million | 23.6 Million | 1.08 Billion | 40.72 Million | 31.83 Million | 561.34 Million |
| Accounts receivables | -22.11 Million | 92.63 Million | -72.05 Million | 44.75 Million | -93.5 Million | -40.54 Million |
| Accounts payables | -3.19 Million | -13.86 Million | 8.11 Million | 20.58 Million | -17.97 Million | 15.81 Million |
| Inventory | 1.53 Million | -1.83 Million | -6.39 Million | -2.79 Million | -96 Thousand | -3.33 Million |
| Other working capital | -70.24 Million | -122.45 Million | -6.92 Million | -49.55 Million | 107.9 Million | -3.49 Million |
| Cash at beginning of period | 348.88 Million | 399.26 Million | 276.47 Million | 352.06 Million | 424.79 Million | 309.03 Million |
| Cash at end of period | 293.99 Million | 348.88 Million | 399.26 Million | 399.26 Million | 352.06 Million | 424.79 Million |
| Capital Expenditure | -20.26 Million | -5.73 Million | -28.01 Million | 819 Thousand | -3.24 Million | -13.07 Million |
| Effect of forex changes on cash | -23 Thousand | -114 Thousand | 352 Thousand | 330 Thousand | -152 Thousand | 70 Thousand |
| Net cash flow / Change in cash | -54.89 Million | -50.37 Million | 122.79 Million | 47.2 Million | -72.73 Million | 115.75 Million |
| Free Cash Flow | -140.14 Million | -155.66 Million | -335.52 Million | 33.68 Million | -112.26 Million | -110.43 Million |
0113
6503
0574
VSTKF
0008
0KBK